The landscape of dementia prognosis has evolved significantly with the appearance of complex biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based checks which will detect Alzheimer's pathology a long time before indications emerge. While these technological advancements signify extraordinary progress in understanding neurodegenerative conditions, they've not dimi... https://harryr753tfq4.wikigop.com/user